EPIGRAL

Epigral Ltd.

NSE: EPIGRAL

BSE: 543332

Sector: Chemicals

Industry Group: Chemicals & Petrochemicals

Industry: Specialty Chemicals

1,101.00-5.9 (-0.53%)

12 Aug, 3:30 PM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

58.1 / 100

Value Score

69.1 / 100

Price Momentum Score

23.7 / 100

QVM Score

47.0 / 100

Key Metrics

Market Cap

4775.28

P/E (TTM)

17.62

P/B

2.15

P/S (TTM)

1.82

EV/EBITDA

9.16

CAPE (5Y)

15.01

ROE (TTM)

16.09

ROCE (TTM)

15.11

ROA (TTM)

9.97

Avg 3Y ROE

18.53

Earnings 3Y CAGR

-1.96

Sales 3Y CAGR

7.56

Sales 5Y CAGR

24.99

Debt/Equity

0.26

Consensus TP

1456.00

Strong Buy %

Promoter Holding

68.83

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Epigral Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is reasonably valued and PE TTM is at a discount to industry median

PE TTM of 17.62 indicates that the stock is reasonably valued on a standalone basis. Discount to industry median P/E is decent at -35.15%

What is P/E Ratio?

Median: 27.17

Value 17.62

0.5796.8

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.26 as on 30 Jun 2026 and Debt to Equity decreased marginally by 0.05 in the last 1 year

What is Debt to Equity?

Consistently pays dividend

The company has not missed dividend payments once in the last 4 financial years

What is Dividend streak?

Negative

Weak price momentum

Price Momentum score of 23.7 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term

What is Price Momentum score?

23.7 / 100

Analysts have been downgrading forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has decreased by -13.16% in the last 3 months, indicating weak earnings momentum

What is Earnings upgrade (3M)?

Not enough data

Low revenue growth and lower than median growth of industry

The company delivered moderate revenue growth of 4.81% for 12-month ended 30 Jun 2026 and the growth was 8.43 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 13.24

Value 4.81

-39.32824.66

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -37.94% for 12-month ended 30 Jun 2026 and the growth was 54.83 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.45%

What is Dividend yield?

Neutral

High ROE but declining trend

The company reported strong ROE of 16.09% for 12-month ended 30 Jun 2026 but ROE declined by -655 bps from 1 year ago

What is ROE (FY)?

High operating margin but declining trend

The company reported strong operating margin of 15.74% for 12-month ended 30 Jun 2026 but operating margin declined by -648 bps from 1 year ago

What is Operating profit margin?

Company's earnings are of moderate quality

Earnings quality score of 63.7 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

63.7 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Epigral Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Epigral Ltd. Shareholding Pattern

Quarterly breakdown of Epigral Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2014	Jul 2015	Jul 2016	Jul 2017	Jul 2018	Jul 2019	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	82.13	75.03	75.03	75.03	75.03	100.00	72.62	71.19	71.18	71.11	71.12	71.21	71.34	71.37	71.38	71.38	71.49	71.58	71.58	68.94	68.95	68.83	68.83	68.83	68.83	68.83
Indian Promoter	82.13	75.03	75.03	75.03	75.03	100.00	72.62	71.19	71.18	71.11	71.12	71.21	71.34	71.37	71.38	71.38	71.49	71.58	71.58	68.94	68.95	68.83	68.83	68.83	68.83	68.83
Foreign Promoter	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.00	24.97	24.97	24.97	24.97	0.00	0.78	1.16	1.51	1.62	1.61	1.34	1.25	1.23	1.21	1.24	1.40	1.67	3.28	7.34	7.69	7.86	7.65	7.51	6.46	6.61
Mutual Funds / UTI	0.00	0.00	0.00	0.00	0.00	0.00	-	-	0.31	0.01	0.00	-	0.03	0.04	0.04	0.05	0.02	0.05	1.04	4.15	4.48	4.59	4.74	5.09	4.90	5.52
FI/Bank/Insurance	0.00	24.97	24.97	24.97	24.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	0.00	0.00	0.00	0.00	0.00	0.00	-	-	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.78	1.16	1.02	1.38	1.40	1.15	1.20	1.16	1.14	1.17	1.36	1.46	2.10	3.01	3.01	3.06	2.71	2.36	1.54	1.03
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.16	0.21	0.19	0.17	0.00	0.00	0.00	0.00	0.00	0.13	0.13	0.16	0.18	0.19	0.18	0.04	0.00	0.04
Non-Institution	17.87	0.00	0.00	0.00	0.00	0.00	26.59	27.66	27.31	27.27	27.26	27.45	27.39	27.40	27.41	27.36	27.10	26.74	25.13	23.72	23.35	23.31	23.52	23.66	24.70	24.55
Bodies Corporate	0.00	0.00	0.00	0.00	0.00	0.00	2.49	2.19	2.01	1.87	2.17	2.14	2.30	2.31	2.45	2.28	3.00	2.96	2.84	2.72	2.78	2.76	2.80	2.82	2.87	2.79
Others (incl. Retail) No. of shareholders	17.87 0	0.00 0	0.00 0	0.00 0	0.00 0	0.00 0	24.10 99,962	25.47 98,147	25.30 91,762	25.40 92,720	25.09 96,948	25.31 96,579	25.09 94,342	25.09 95,395	24.96 95,305	25.08 92,523	24.10 88,444	23.78 85,299	22.29 82,710	21.00 81,245	20.57 80,420	20.55 79,515	20.72 78,189	20.84 77,158	21.83 77,217	21.76 75,946

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	SHI: Specialty Chemicals	2.04%	20 / 20

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Epigral Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
RAMESHBHAI MEGHJIBHAI PATEL Promoter	June-2023	Market Purchase (Acquisition) 5th Jun 2023	7.04 %	₹ 967.57	5.00 k	₹ 48.38 lac
RAMESHBHAI MEGHJIBHAI PATEL Promoter	June-2023	Market Purchase (Acquisition) 1st Jun 2023	7.03 %	₹ 920.46	5.00 k	₹ 46.02 lac
MAULIK JAYANTIBHAI PATEL Promoter	March-2023	Market Purchase (Acquisition) 20th Mar 2023	5.18 %	₹ 898.81	800.00	₹ 7.19 lac
MAULIK JAYANTIBHAI PATEL Promoter	March-2023	Market Purchase (Acquisition) 17th Mar 2023	5.18 %	₹ 889.20	2.00 k	₹ 17.78 lac
MAULIK JAYANTIBHAI PATEL Promoter	March-2023	Market Purchase (Acquisition) 16th Mar 2023	5.17 %	₹ 952.18	4.50 k	₹ 42.85 lac
MAULIK JAYANTIBHAI PATEL Promoter	March-2023	Market Purchase (Acquisition) 15th Mar 2023	5.16 %	₹ 967.67	5.00 k	₹ 48.38 lac
MAULIK JAYANTIBHAI PATEL Promoter	March-2023	Market Purchase (Acquisition) 7th Mar 2023	5.15 %	₹ 1,024.65	1.28 k	₹ 13.14 lac
MAULIK JAYANTIBHAI PATEL Promoter	March-2023	Market Purchase (Acquisition) 1st Mar 2023	5.15 %	₹ 993.18	2.00 k	₹ 19.86 lac
MAULIK JAYANTIBHAI PATEL Promoter	February-2023	Market Purchase (Acquisition) 28th Feb 2023	5.14 %	₹ 1,012.89	5.00 k	₹ 50.64 lac
MAULIK JAYANTIBHAI PATEL Promoter	February-2023	Market Purchase (Acquisition) 22nd Feb 2023	5.13 %	₹ 1,047.87	3.80 k	₹ 39.82 lac

…

Corporate Actions

History of Epigral Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 5/share
Record date: 1st Jun 2026Ex-date: 1st Jun 2026
Announced on: 3rd May 2026
Dividend₹ 3.50/share
Record date: 21st Jun 2025Ex-date: 20th Jun 2025
Announced on: 5th May 2025
Dividend₹ 2.50/share
Record date: 7th Feb 2025Ex-date: 7th Feb 2025
Announced on: 27th Jan 2025
Dividend₹ 5/share
Record date: 2nd Jul 2024Ex-date: 2nd Jul 2024
Announced on: 9th Apr 2024
Dividend₹ 2.50/share
Record date: 20th Jun 2023Ex-date: 20th Jun 2023
Announced on: 25th Apr 2023

Company Profile

Overview of Epigral Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Epigral Limited is an India-based manufacturer of essential chemicals. The Company is engaged in the manufacturing and selling of chemicals, including derivatives and specialty chemicals. It operates under two businesses, Chlor-Alkali and Derivatives and Speciality chemicals, which relate to the man...

Key personnel

Mr. Rakesh Agrawal

Chief Financial Officer

Mr. Gaurang Ghanshyam Trivedi

Compliance Officer, Company Secretary

Mr. Maulik PatelD

Chairman of the Board, Managing Director

Mr. Kaushal SoparkarD

Executive Director

Mr. Ankit PatelD

Non-Executive Non-Independent Director

Mr. Darshan PatelD

Non-Executive Non-Independent Director

Mr. Karana PatelD

Non-Executive Non-Independent Director

Mr. Sanjay Khatau AsherD

Non-Executive Independent Director

View all

Incorporated on

11 Sep 2007

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

1,135

IPO date

18 Aug 2021

Free Float

1,34,33,376

Website

https://epigral.com/

Phone no.

+917929709600

Address

Epigral Tower, B/h. Safal Profitaire, Corporate Road, AHMEDABAD, 380015, India

Frequently Asked Questions

What is the current share price of Epigral Ltd.?

The current share price of Epigral Ltd. is ₹ 1,101.00 as of 12 Aug 2026.

What is the market capitalisation of Epigral Ltd.?

The market capitalisation of Epigral Ltd. stands at ₹ 4,775.28 Cr.

What is the PE ratio of Epigral Ltd.?

The Price-to-Earnings (PE) ratio of Epigral Ltd. is 17.62 as of the latest trailing twelve months data.

What is the ROE and ROCE of Epigral Ltd.?

Epigral Ltd. has a Return on Equity (ROE) of 16.09% and a Return on Capital Employed (ROCE) of 15.11% as per the latest financial reports.

What is the 52-week high and low of Epigral Ltd.?

The 52-week high of Epigral Ltd. is - and the 52-week low is -.

What is the dividend yield of Epigral Ltd.?

The dividend yield of Epigral Ltd. is 0.45% based on the current market price.

What is the FII and DII holding in Epigral Ltd.?

Foreign Institutional Investors (FII) hold 1.03%, Domestic Institutional Investors (DII) hold 5.52% and retail/public investors hold 21.76% of Epigral Ltd. shares.

What sector does Epigral Ltd. belong to?

Epigral Ltd. operates in the Chemicals sector.

What is the beta of Epigral Ltd.?

The beta of Epigral Ltd. is 1.25, indicating its price volatility relative to the broader market. Over the past 1 year, Epigral Ltd. has delivered an absolute return of -43.42%.

What is the RSI of Epigral Ltd.?

The 14-day Relative Strength Index (RSI) of Epigral Ltd. is 49.99, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Epigral Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Epigral Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Holdings and Presence

Corporate Actions

Company Profile